10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Antimicrobial Drug Resistance poses a growing threat to global health, challenging our ability to treat bacterial, viral, and fungal infections effectively. The overuse and misuse of antimicrobial drugs contribute significantly to the development of resistance, rendering once-potent medications less effective. This complex issue arises from factors such as improper prescription practices, patient non-compliance, and the widespread use of antibiotics in agriculture. The emergence of multidrug-resistant strains heightens the urgency of addressing this crisis. Resistant infections lead to prolonged illness, increased healthcare costs, and higher mortality rates. The need for innovative research and development of new antimicrobial agents becomes paramount to stay ahead of evolving resistance mechanisms.
By signing up, you agree to join our mailing list to receive information and updates.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : The impact of expanded adolescent vaccination against Omicron waves depends on the epidemic status: A mathematical modelling study
Anna Fairweather, University of Oxford, United Kingdom
Title : Comprehensive HIV care through integrated STI and primary care services at the LGBTQ+ Center of Southern Nevada
Darya V Fridman, The Southern Nevada LGBTQ+ Center, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Meeting the needs of adults aged 50+ with HIV through the new opening of a primary care clinic at the LGBTQ Center of Southern Nevada
Darya V Fridman, The Southern Nevada LGBTQ+ Center, United States
Title : Common infections in cancer patients – narrative review and clinical pearls
Patricia Tai, University of Saskatchewan, Canada